Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic role of dipeptidyl peptidase 4 (DPP4) in primary human (pre)adipocytes
Pia Zilleßen, Jennifer Celner, Anita Kretschmann, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Recently isolated antidiabetic hydrolysates and peptides from multiple food sources: a review
Bababode Adesegun Kehinde, Poorva Sharma
Critical Reviews in Food Science and Nutrition (2018) Vol. 60, Iss. 2, pp. 322-340
Closed Access | Times Cited: 128
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
Elodie M. Varin, Erin E. Mulvihill, Jacqueline L. Beaudry, et al.
Cell Metabolism (2018) Vol. 29, Iss. 2, pp. 320-334.e5
Open Access | Times Cited: 119
Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial–Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis
Fan Yang, Yuta Takagaki, Yasuo Yoshitomi, et al.
Cancer Research (2018) Vol. 79, Iss. 4, pp. 735-746
Open Access | Times Cited: 110
Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin
Fengwu Li, Christopher A. Adase, Ling‐juan Zhang
Journal of Visualized Experiments (2017), Iss. 125
Open Access | Times Cited: 76
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation
Ilaria Barchetta, Flavia Agata Cimini, Gea Ciccarelli, et al.
Journal of Endocrinological Investigation (2019) Vol. 42, Iss. 11, pp. 1257-1272
Closed Access | Times Cited: 65
MALAT1 Up-Regulator Polydatin Protects Brain Microvascular Integrity and Ameliorates Stroke Through C/EBPβ/MALAT1/CREB/PGC-1α/PPARγ Pathway
Wenchen Ruan, Jingwei Li, Yazhou Xu, et al.
Cellular and Molecular Neurobiology (2019) Vol. 39, Iss. 2, pp. 265-286
Closed Access | Times Cited: 64
Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein
Nanjaiah Lalitha, Bettadahalli Sadashivaiah, T. R. Ramaprasad, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0231543-e0231543
Open Access | Times Cited: 43
Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis
Ilaria Barchetta, Flavia Agata Cimini, Sara Dule, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2306-2306
Open Access | Times Cited: 27
DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
Eun Ju Bae
Archives of Pharmacal Research (2016) Vol. 39, Iss. 8, pp. 1114-1128
Closed Access | Times Cited: 47
Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
Kristina Schlicht, Nathalie Rohmann, Corinna Geisler, et al.
International Journal of Obesity (2020) Vol. 44, Iss. 11, pp. 2335-2338
Open Access | Times Cited: 39
The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism
Yang Qiu, Fu Bing, Dan Luo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Endogenous glucagon‐like peptide (GLP)‐1 as alternative for GLP‐1 receptor agonists: Could this work and how?
Mark M. Smits, Jens J. Holst
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 8
Open Access | Times Cited: 12
Lipidomics and single-cell RNA sequencing reveal lipid and cell dynamics of porcine glycerol-injured skeletal muscle regeneration model
Ye Sun, Ziye Xu, Wenjing You, et al.
Life Sciences (2024) Vol. 350, pp. 122742-122742
Closed Access | Times Cited: 4
Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance
Radwan H. Ahmed, Hasniza Zaman Huri, Sekaran Muniandy, et al.
Clinical Biochemistry (2017) Vol. 50, Iss. 13-14, pp. 746-749
Closed Access | Times Cited: 34
DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
Tania Romacho, Henrike Sell, Ira Indrakusuma, et al.
AJP Endocrinology and Metabolism (2019) Vol. 318, Iss. 5, pp. E590-E599
Closed Access | Times Cited: 30
Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
Bing Yang, Liqing Lu, Dongmei Zhou, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 18
Screening of Genes Related to Fat Deposition of Pekin Ducks Based on Transcriptome Analysis
Bozhi Shi, Ziyue Zhang, Xueze Lv, et al.
Animals (2024) Vol. 14, Iss. 2, pp. 268-268
Open Access | Times Cited: 3
Dipeptidyl peptidase‐4 disturbs adipocyte differentiation via the negative regulation of the glucagon‐like peptide‐1/adiponectin‐cathepsin K axis in mice under chronic stress conditions
Meiping Zhang, Xueling Yue, Shengnan Xu, et al.
The FASEB Journal (2024) Vol. 38, Iss. 10
Open Access | Times Cited: 3
Potential Role of Dipeptidyl Peptidase−4 in Regulating Mitochondria and Oxidative Stress in Cardiomyocytes
Shih-Yi Lee, Shao-Tung Wu, Chen-Xuan Du, et al.
Cardiovascular Toxicology (2024) Vol. 24, Iss. 10, pp. 1090-1104
Closed Access | Times Cited: 3
Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
Kornél Király, Márk Kozsurek, Erika Lukácsi, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Metabolic effects of antidiabetic drugs on adipocytes and adipokine expression
Habib Yaribeygi, Luis E. Simental‐Mendía, George E. Barreto, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 10, pp. 16987-16997
Closed Access | Times Cited: 28
The Impact of Incretin-Based Medications on Lipid Metabolism
Habib Yaribeygi, Mina Maleki, Alexandra E. Butler, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 21
CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma
Sohji Nishina, Keisuke Hino
Cancers (2022) Vol. 14, Iss. 2, pp. 454-454
Open Access | Times Cited: 15
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease
Federico Bernardini, Annunziata Nusca, Federica Coletti, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1858-1858
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top